Retinal vein occlusion (RVO) is an interruption of the normal venous drainage from the retinal tissue. Either the central vein or one of its branches can become occluded. Uncommonly, the occlusion can occur in a vein that drains half of the retina. This is referred to as a hemiretinal vein occlusion (HRVO).
RVO is divided into two types, i.e Central retinal vein occlusion (CRVO) and Branch retinal vein occlusion (BRVO). CRVO is a condition when there is blockage in the main vein of the retina, which is called the central retinal vein, and BRVO occurs when the blockage is in a smaller branch of veins throughout the retina.Characteristically, in the retina proximal to the occlusion, the affected venous system is tortuous and dilated, and there are several intraretinal hemorrhages and retinal edema. Retinal vein occlusions are usually painless, sudden, and unilateral causes of vision loss.
The condition can occasionally lead to complications and more serious symptoms. Vision may be severely and permanently affected if any of the following complications occur, that includes, macular edema, neovascularization, neovascular glaucoma, and retinal detachment. There’s no medication available that’s specific for retinal artery occlusions. Most people with this condition will have permanent changes to their vision.
Get FREE sample copy at:
The Retinal Vein Occlusion market report also covers emerging drugs, current treatment practices, Retinal Vein Occlusion market share of the individual therapies, current and forecasted Retinal Vein Occlusion Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Retinal Vein Occlusion treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Retinal Vein Occlusion Market Key Facts
As per The European Society of Retina Specialists (EURETINA) more than 1.1 million people over the age of 55 years are currently affected by a RVO in the EU with 15–25% due to CRVO and 75–80% due to BRVO. This corresponds to a prevalence of RVO in either eye of 0.7%.
According to the study conducted by Kolar et al., titled “Risk Factors for Central and Branch Retinal Vein Occlusion: A Meta-Analysis of Published Clinical Data,” RVO is more prevalent in men than women and is more frequent in older age (over 65 years).
Among the RVO patients, males show higher proportion of prevalence of RVO as compared to females in the 7MM
Key Benefits of Retinal Vein Occlusion Market Report
Retinal Vein Occlusion market report provides an in-depth analysis of Retinal Vein Occlusion Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
The Retinal Vein Occlusion market report will help in developing business strategies by understanding the Retinal Vein Occlusion Market trends & developments, key players and future market competition that will shape and drive the Retinal Vein Occlusion market in the upcoming years.
The Retinal Vein Occlusion market report covers Retinal Vein Occlusion current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Retinal Vein Occlusion market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Currently, there is no treatment that can reverse the blocked vein. The aims of treatment are to detect and treat any underlying risk factors for the condition and also to detect and treat any complications where possible.
The anti-VEGF agents are considered as the first line of therapy for the treatment of Mo, however other surgical options such as laser photocoagulation therapy are also explored. At this time, no well determined prophylactic treatment for MO is available. Hence, early diagnosis and proper management of the disease is necessary to prevent vision loss. The market size shall grow during the forecast period owing to the launch of upcoming therapies. The market size is expected to increase at a significant rate during the study period.
The Retinal Vein Occlusion market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Retinal Vein Occlusion market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Retinal Vein Occlusion market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Retinal Vein Occlusion Epidemiology
The Retinal Vein Occlusion epidemiology section covers insights about historical and current Retinal Vein Occlusion patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Retinal Vein Occlusion Drugs Uptake and Key Market Players
The Retinal Vein Occlusion Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Retinal Vein Occlusion market or expected to get launched in the market during the study period. The analysis covers Retinal Vein Occlusion market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Some of the key players in the Retinal Vein Occlusion market includes:
And many others
And many others.
Table of Content
1. Key Insights
2. Executive Summary
3. Retinal Vein Occlusion Competitive Intelligence Analysis
4. Retinal Vein Occlusion Market Overview at a Glance
5. Retinal Vein Occlusion Disease Background and Overview
6. Retinal Vein Occlusion Patient Journey
7. Retinal Vein Occlusion Epidemiology and Patient Population
8. Retinal Vein Occlusion Treatment Algorithm, Current Treatment, and Medical Practices
9. Retinal Vein Occlusion Unmet Needs
10. Key Endpoints of Retinal Vein Occlusion Treatment
11. Retinal Vein Occlusion Marketed Products
12. Retinal Vein Occlusion Emerging Therapies
13. Retinal Vein Occlusion Seven Major Market Analysis
14. Attribute Analysis
15. Retinal Vein Occlusion Market Outlook (7 major markets)
16. Retinal Vein Occlusion Access and Reimbursement Overview
17. KOL Views on the Retinal Vein Occlusion Market.
18. Retinal Vein Occlusion Market Drivers
19. Retinal Vein Occlusion Market Barriers
21. DelveInsight Capabilities
DelveInsight’s Retinal Vein Occlusion Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Retinal Vein Occlusion in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Retinal Vein Occlusion Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Retinal Vein Occlusion market.
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States